An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity: Clinical article

Journal of Neurosurgery

Volumn 120, Issue 4, 2014, Pages 846-853

  Oppenlander, Mark E ^a   Wolf, Andrew B ^a   Snyder, Laura A ^a   Bina, Robert ^a   Wilson, Jeffrey R ^b   Coons, Stephen W ^a   Ashby, Lynn S ^a   Brachman, David ^a   Nakaji, Peter ^a   Porter, Randall W ^a   Smith, Kris A ^a   Spetzler, Robert F ^a   Sanai, Nader ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

Author keywords

Extent of resection; Glioblastoma; Glioma; Oncology; Progression free survival; Volumetric analysis

Indexed keywords

TEMOZOLOMIDE;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; CANCER SURVIVAL; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; KARNOFSKY PERFORMANCE STATUS; MAJOR CLINICAL STUDY; MALE; MICROSURGERY; MORBIDITY; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROSURGERY; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REOPERATION; RISK ASSESSMENT; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; DISEASE PROGRESSION; FEMALE; GLIOBLASTOMA; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEUROSURGICAL PROCEDURES; PROGNOSIS; REOPERATION; TREATMENT OUTCOME; UNITED STATES;

EID: 84897938217     PISSN: 00223085     EISSN: 19330693     Source Type: Journal    
DOI: 10.3171/2013.12.JNS13184     Document Type: Article

References (32)

1. Barker FG II, Chang SM, Gutin PH, Malec MK, McDermott MW, Prados MD, et al: Survival and functional status after resection of recurrent glioblastoma multiforme. Neurosurgery 42:709-723, 1998 (Pubitemid 28208354)
2. Berger MS, Cohen WA, Ojemann GA: Correlation of motor cortex brain mapping data with magnetic resonance imaging. J Neurosurg 72:383-387, 1990 (Pubitemid 20072960)
3. Bloch O, Han SJ, Cha S, Sun MZ, Aghi MK, McDermott MW, et al: Impact of extent of resection for recurrent glioblastoma on overall survival. Clinical article. J Neurosurg 117:1032-1038, 2012
4. Brott T, Adams HP Jr, Olinger CP, Marler JR, Barsan WG, Biller J, et al: Measurements of acute cerebral infarction: a clinical examination scale. Stroke 20:864-870, 1989 (Pubitemid 19188240)
5. Chaichana KL, Zadnik P, Weingart JD, Olivi A, Gallia GL, Blakeley J, et al: Multiple resections for patients with glioblastoma: prolonging survival. Clinical article. J Neurosurg 118: 812-820, 2013
6. Clarke JL, Ennis MM, Yung WK, Chang SM, Wen PY, Cloughesy TF, et al: Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma? Neuro Oncol 13: 1118-1124, 2011
7. Dirks P, Bernstein M, Muller PJ, Tucker WS: The value of reoperation for recurrent glioblastoma. Can J Surg 36:271-275, 1993 (Pubitemid 23248140)
8. Fleiss JL: The Design and Analysis of Clinical Experiments. New York: Wiley, 1986
9. Goldstein LB, Bertels C, Davis JN: Interrater reliability of the NIH stroke scale. Arch Neurol 46:660-662, 1989 (Pubitemid 19150945)
10. Guyotat J, Signorelli F, Frappaz D, Madarassy G, Ricci AC, Bret P: Is reoperation for recurrence of glioblastoma justified? Oncol Rep 7:899-904, 2000
11. Hardesty DA, Sanai N: The value of glioma extent of resection in the modern neurosurgical era. Front Neurol 3:140, 2012
12. Harsh GR IV, Levin VA, Gutin PH, Seager M, Silver P, Wilson CB: Reoperation for recurrent glioblastoma and anaplastic astrocytoma. Neurosurgery 21:615-621, 1987 (Pubitemid 18001497)
13. Hegi ME, Diserens AC, Gorlia T, Hamou MF, de Tribolet N, Weller M, et al: MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997-1003, 2005 (Pubitemid 40349502)
14. Helseth R, Helseth E, Johannesen TB, Langberg CW, Lote K, Rønning P, et al: Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme. Acta Neurol Scand 122:159-167, 2010
15. Hess KR: Extent of resection as a prognostic variable in the treatment of gliomas. J Neurooncol 42:227-231, 1999
16. Kido DK, LeMay M, Levinson AW, Benson WE: Computed tomographic localization of the precentral gyrus. Radiology 135:373-377, 1980 (Pubitemid 10105907)
17. Kline P: The Handbook of Psychological Testing, ed 2. London: Routledge, 2000
18. Lacroix M, Abi-Said D, Fourney DR, Gokaslan ZL, Shi W, DeMonte F, et al: A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190-198, 2001 (Pubitemid 32799739)
19. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, et al: The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114:97-109, 2007 (Pubitemid 47103521)
20. Mandl ES, Dirven CM, Buis DR, Postma TJ, Vandertop WP: Repeated surgery for glioblastoma multiforme: only in combination with other salvage therapy. Surg Neurol 69:506-509, 2008
21. McGirt MJ, Mukherjee D, Chaichana KL, Than KD, Weingart JD, Quinones-Hinojosa A: Association of surgically acquired motor and language deficits on overall survival after resection of glioblastoma multiforme. Neurosurgery 65:463-470, 2009
22. Mineo JF, Bordron A, Baroncini M, Ramirez C, Maurage CA, Blond S, et al: Prognosis factors of survival time in patients with glioblastoma multiforme: a multivariate analysis of 340 patients. Acta Neurochir (Wien) 149:245-253, 2007
23. Pinsker M, Lumenta C: Experiences with reoperation on recurrent glioblastoma multiforme. Zentralbl Neurochir 62:43-47, 2001 (Pubitemid 34083899)
24. Pouratian N, Bookheimer SY: The reliability of neuroanatomy as a predictor of eloquence: a review. Neurosurg Focus 28(2):E3, 2010
25. Sanai N, Polley MY, McDermott MW, Parsa AT, Berger MS: An extent of resection threshold for newly diagnosed glioblastomas. Clinical article. J Neurosurg 115:3-8, 2011
26. Sanai N, Snyder LA, Honea NJ, Coons SW, Eschbacher JM, Smith KA, et al: Intraoperative confocal microscopy in the visualization of 5-aminolevulinic acid fluorescence in low-grade gliomas. Clinical article. J Neurosurg 115:740-748, 2011
27. Skirboll SS, Ojemann GA, Berger MS, Lettich E, Winn HR: Functional cortex and subcortical white matter located within gliomas. Neurosurgery 38:678-685, 1996 (Pubitemid 26087873)
28. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, et al: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352:987-996, 2005 (Pubitemid 40349501)
29. Tavakol M, Dennick R: Making sense of Cronbach's alpha. Int J Med Ed 2:53-55, 2011
30. Weir JP: Quantifying test-retest reliability using the intraclass correlation coefficient and the SEM. J Strength Cond Res 19:231-240, 2005
31. Wen PY, Kesari S: Malignant gliomas in adults. N Engl J Med 359:492-507, 2008
32. Williams LS, Yilmaz EY, Lopez-Yunez AM: Retrospective assessment of initial stroke severity with the NIH Stroke Scale. Stroke 31:858-862, 2000 (Pubitemid 30198428)